COHR

Business Context and Reporting Period

This Form 10-Q covers II-VI Incorporated (referred to as Coherent Corp. in the request metadata, but identified as II-VI in the filing) for the quarterly period ended March 31, 2004. The company designs, manufactures, and markets optical and electro-optical components and materials, primarily for high-power CO2 lasers, medical, scientific, and military applications. Operations are organized into four reportable segments: Infrared Optics, Near-Infrared Optics, Military Infrared Optics, and the Compound Semiconductor Group.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 21% year-over-year for the quarter and 13% for the nine-month period. Growth was driven by stronger shipments of infrared optics to OEM and aftermarket customers in Japan, Europe, and the U.S.
• Profitability Surge: Net earnings rose 58% for the quarter and 42% for the nine-month period. Segment earnings increased 76% for the quarter, attributed to higher gross margins from increased manufacturing in Asian facilities (specifically China), yield improvements, and a strong Japanese Yen.
• Debt Reduction: Total debt decreased from $23.7 million at June 30, 2003, to $18.1 million at March 31, 2004. Interest expense dropped significantly due to lower debt levels and lower LIBOR rates.
• Segment Performance:
  • Infrared Optics: Revenues up 20% (quarter) and 14% (9mo); earnings up 20% (quarter).
  • Military Infrared Optics: Revenues up 22% (quarter) due to replacement parts for the Iraq war; segment earnings turned positive ($276k) from a loss ($453k) in the prior year.
  • Compound Semiconductor Group: Revenues up 31% (quarter) driven by medical imaging detectors and homeland security spectrometers; losses narrowed significantly.

Guidance, Outlook, and Risks

• Outlook: Management expects cash flow from operations, existing reserves, and borrowing capacity to be sufficient to fund working capital, capital expenditures, and debt payments for fiscal 2004. The company anticipates continued demand for military replacement parts and growth in medical and industrial markets.
• Acquisitions: The company acquired a 75% interest in II-VI LOT Suisse S.a.r.l. (Switzerland) for approximately $1.8 million and is in the process of acquiring UV filter assets from Coherent, Inc. for $2.0 million.
• Risks and Contingencies:
  • Legal: A jury awarded the company $0.8 million in a trade secret lawsuit; however, punitive damages and attorney fees were denied by the court. The award remains subject to appeal.
  • Market Risk: The company is exposed to foreign currency fluctuations, particularly the Japanese Yen. A 10% change in the Yen-to-dollar rate would impact revenues by approximately $1.3 million (9mo).
  • Interest Rate Risk: The company has floating rate debt; a 1% change in interest rates would impact interest expense by approximately $157,000 (9mo).
• Unusual Items: The company terminated its Shareholder Rights Plan, redeeming rights for $144,000. Contract research and development bookings decreased year-over-year due to the non-repetition of specific large government contracts from the prior year.

Investor Verification Checklist

• Sustainability of Margins: Verify if the 46% manufacturing gross margin is sustainable given the reliance on Asian manufacturing costs and the strength of the Yen.
• Military Segment Volatility: Assess the dependency on government contracts and the impact of the "stop-work order" mentioned in the Military Infrared Optics segment.
• Debt Covenants: Confirm compliance with the amended credit facility covenants, specifically the new minimum consolidated debt service coverage ratio.
• Acquisition Integration: Monitor the integration and performance of the newly acquired II-VI LOT Suisse entity and the Coherent UV filter assets.
• Legal Resolution: Track the status of the trade secret lawsuit appeal regarding the $0.8 million verdict.